Why ownership is the first investor question
When an international party studies Thailand's medical-cannabis value chain, the first serious question is rarely about the plant. It is about ownership. Can a foreign investor lawfully hold equity in a Thai operation, keep the upside, and repatriate returns without entering arrangements that are illegal under Thai law?
For a well-chosen activity, the answer is yes. The instrument that makes it lawful is a promotion from Thailand's Board of Investment (BOI).
This post explains, in general terms, how BOI promotion works for a foreign investor, why it is the correct ownership route, and where a broker fits. It does not quote tax percentages or promotion-code numbers. Those are set by the BOI and shift with each policy revision. Confirm every specific with the BOI and Thai counsel before you model returns.
What BOI promotion actually is
The Board of Investment is the Thai government agency that grants investment promotion to activities the country wants to attract. When a project is promoted, the promoted company receives a defined package of privileges. In broad terms these fall into two families.
The first is tax privileges: relief on corporate income tax for a defined period, plus exemptions or reductions on import duties for qualifying machinery and inputs.
The second, and often the more decisive, is ownership and operational privilege. In activities where the ordinary Foreign Business Act would cap foreign shareholding, promotion can allow a foreign party to hold a majority or even the whole of a promoted company, with easier work-permit and land-holding treatment alongside it.
Promotion is activity-specific. The BOI publishes categories of eligible activities, and a project qualifies only if it maps onto one of them and meets the attached conditions. Some agricultural, biotechnology, processing, and manufacturing activities have historically been promotable. Whether a given medical-cannabis activity qualifies, and on what terms, is a question for the BOI and counsel, not an assumption. Treat no category number or incentive figure you read online as current.
Why nominee structures are the thing to avoid
Thailand's Foreign Business Act restricts foreign majority ownership across many activities. The temptation some newcomers meet is a nominee arrangement: a Thai national or entity holds shares on the foreigner's behalf while the foreigner controls the economics.
This is illegal under Section 36 of the Foreign Business Act. It carries criminal exposure for every party, and it renders the structure unbankable and unsellable the moment anyone runs genuine due diligence.
BOI promotion is the opposite. It is a formal, published grant of the right to foreign ownership in a defined activity. Where a nominee structure hides foreign control, a BOI-promoted company is expressly authorised to hold it. A lawful joint venture with a licensed Thai partner is the other clean route, often used alongside or ahead of a BOI application.
If anyone offers a nominee shortcut, read it as the clearest possible signal to walk away. The whole premise of a defensible entry is that it survives scrutiny.
Where cultivation licensing and export eligibility sit
BOI promotion answers the ownership and tax question. It does not, on its own, licence anyone to grow or move cannabis. Those licences are separate and specific.
On the cultivation and supply side, Thailand's regulator recognises defined categories that may participate in the licensed export chain: hospitals under the Sanatorium Act, herbal-product manufacturing or sales licence holders, drug manufacturing or sales licence holders, Category-5 narcotics (cannabis and hemp extract) licence holders, certified traditional healers, and cultivation sites supplying licensed buyers. We set out how those categories gate the licensed export chain in our DTAM export briefing.
So a real entry has two layers that must be built together: a lawful ownership vehicle (BOI-promoted and/or a joint venture) and a licensed operating position within the recognised cultivation-and-supply framework. One without the other leaves you with a company that can hold equity but cannot trade, or a licence held by a structure a foreign investor cannot lawfully own.
Where CannaBless fits
CannaBless is a medical-cannabis export brokerage. We do not hold export inventory and we are not an exporter. Licensed Thai farms cultivate and hold the licences. We register those farms, facilitate their TH-GACP and export-licensing documentation, and connect them to licensed importers in the served markets: Switzerland, Germany, and France as priorities, plus the United Kingdom, Australia, and the Czech Republic.
For an investor, that broker position is the practical value. We help align the ownership vehicle with the licensed supply position: mapping the intended activity against the lawful routes, coordinating with Thai counsel on the BOI application or joint-venture terms, and connecting the resulting entity to a licensed cultivation network and to licensed demand.
That demand side is documented, not hypothetical. A completed shipment of 700 kg of Cannabis Sativa L. under Italian import permit IT-20261155773424, arriving Genova in June 2026, phytosanitary-certified and GACP-aligned, is the public proof point that the downstream channel works. For how European demand is licensed, see our BfArM import-pathway briefing.
None of this is investment, tax, or legal advice, and no rate here is promised. BOI privileges and promotion categories must be confirmed with the BOI and Thai counsel for your specific project.
Talk to the export desk
If you are weighing a lawful entry into the Thai medical-cannabis value chain, the fastest way to know whether it is buildable is a short scoping conversation. We will map your intended activity against the lawful ownership routes, flag what belongs with the BOI and with counsel, and show you where a licensed supply position and licensed demand already exist.
This is not legal advice; confirm every structure and privilege with Thai counsel before you commit capital.